CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
We have now added a new section called the "Assay History List" to the "At A Gla...
We are very excited to launch our new website! Please take a few moments to click around and explore...